GAITHERSBURG, Md.--(BUSINESS WIRE)--Ore Pharmaceuticals Inc. (NASDAQ:ORXE) today reported financial results for the second quarter ended June 30, 2009. During the second quarter of 2009, Ore Pharmaceuticals continued its transformation into a pharmaceutical asset management company. The Company’s strategy is focused on acquiring interests in pharmaceutical assets whose value, Ore believes, it can significantly enhance through targeted development, with the goal of then monetizing these assets through a sale or out-licensing. Steps taken during the second quarter and since in advancing towards that goal include:
